06855.HK
Ascentage Pharma Group International Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 29.56
−1.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.18x
- Price / sales
- 14.23x
- Price / cash flow
- -6.52x
Enterprise value
- Enterprise value
- HKD 10.8B
- EV / sales
- 14.56x
- EV / EBITDA
- -7.09x
- EV / EBIT
- -6.66x
- Market cap
- HKD 10.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026